LYNX1 and Cognitive impairment: Moreover, treatment with a water-soluble LYNX1 analogue was shown to prevent amyloid beta-induced blockade of memory-related synaptic plasticity, indicating LYNX1 may be a potential therapeutic target for improving cognitive deficits in neurodegenerative diseases61.